INS and diabetes mellitus: In fact, sustained lowering FAs levels achieved with long-term therapy Acipimox was shown to increase insulin secretion rates in a subset of patients with diabetes (Davoren et al. 1998) or at risk of diabetes (Paolisso et al. 1998), suggesting that FFAs homeostasis is important for insulin secretion regulation, especially in people at risk.